Dicerna Pharmaceuticals Garners $8,400,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
    Dicerna Pharmaceuticals
  • Mailing Address
    15 Peterson Circle Sudbury, MA 01776
  • Company Description
    Dicerna Pharmaceuticals is a venture-backed startup developing novel therapeutics in multiple therapeutic areas based on Dicer substrate technology, which makes use of the RNA interference mechanism.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Abingworth Management Inc
  • Venture Investor
    Oxford Bioscience Partners
  • Venture Investor
    Skyline Ventures

Trending on Xconomy